What is the impact of oral probiotic supplementation on the HOMA-IR insulin resistance index in pregnant women with gestational diabetes mellitus without antidiabetic medication during the current pregnancy? A systematic review and meta-analysis
5 affiliations
- 1Aristotle University of Thessaloniki
- 2University of Birmingham
- 3Aretaieio University Hospital, National and Kapodistrian University of Athens
- 4Aristotle University of Thessaloniki, Papageorgiou General Hospital
- 5Gynecology Clinic, General Hospital of Athens “LAIKO”
Abstract
Background Gestational diabetes mellitus (GDM) is a common pregnancy complication, with an estimated global prevalence of up to 14%. While lifestyle and genetic risk factors for GDM are well documented, the effect of probiotic supplementation on the management of GDM-specifically through the reduction of insulin resistance as measured by the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) index-has not been systematically evaluated. Objective This meta-analysis aimed to quantitatively evaluate the clinical efficacy of probiotic supplementation in reducing the HOMA-IR index in a population of pregnant women with diagnosed GDM who manage the disease without the use of antidiabetic pharmacotherapy (insulin or oral agents), as well as to address the probiotics as an evidence-based, adjunctive therapeutic strategy for a more effective regulation of the metabolic profile during pregnancy. Methods PubMed, Scopus, and Cochrane databases were searched for original research articles published up to August 10, 2025, which could potentially evaluate the impact of oral probiotic supplementation to the reduction of the HOMA-IR insulin resistance index in pregnant women with GDM without antidiabetic medication during the current pregnancy. A random-effects model was applied to estimate weighted mean differences (MDs) and 95% confidence intervals (CIs). Results Four randomized controlled trials comprising 245 women (128 in the probiotic group and 126 in the placebo group) were included. The meta-analysis demonstrated a statistically significant reduction in the HOMA-IR levels in the intervention group compared to the control group (weighted MD: -0.51, 95% CI: -0.90 to -0.11, p = 0.01). Significant heterogeneity was observed among the studies (I2 = 61.3%). Conclusion The administration of probiotics appears to improve insulin sensitivity in women with GDM and may serve as a useful adjunctive therapy.
Related
- ABCC2 rs2273697, rs717620, rs3740066 polymorphisms and antiseizure medication resistance: a systematic review and meta-analysis
- Chemotherapy resistance and risk stratification in gestational trophoblastic neoplasia: A systematic review and network meta‐analysis
- Effects of Bioactive Compound Supplementation on Insulin Resistance and Systemic Inflammation in Overweight and Obese Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- A Systematic Review of Antidiabetic Mechanisms of Passiflora edulis: Beyond Glycemic Control.
- A randomized controlled double-blinded trial to assess the risk of gestational diabetes mellitus in non-anemic pregnant women who receive oral iron supplementation
BibTeX
@article{koutsogeorgopoulou2026what,
title = {{What is the impact of oral probiotic supplementation on the HOMA-IR insulin resistance index in pregnant women with gestational diabetes mellitus without antidiabetic medication during the current pregnancy? A systematic review and meta-analysis}},
author = {Georgia Koutsogeorgopoulou and Ilias Liapis and Christos Chatzakis and Alexandros Sotiriadis and Charalampos Karachalios},
journal = {The Egyptian Journal of Internal Medicine},
year = {2026},
month = oct,
doi = {10.1186/s43162-026-00747-3},
url = {https://doi.org/10.1186/s43162-026-00747-3},
note = {CC BY},
}
RIS
TY - JOUR
TI - What is the impact of oral probiotic supplementation on the HOMA-IR insulin resistance index in pregnant women with gestational diabetes mellitus without antidiabetic medication during the current pregnancy? A systematic review and meta-analysis
AU - Georgia Koutsogeorgopoulou
AU - Ilias Liapis
AU - Christos Chatzakis
AU - Alexandros Sotiriadis
AU - Charalampos Karachalios
PY - 2026
DA - 2026/10/25
JO - The Egyptian Journal of Internal Medicine
DO - 10.1186/s43162-026-00747-3
UR - https://doi.org/10.1186/s43162-026-00747-3
AB - Background Gestational diabetes mellitus (GDM) is a common pregnancy complication, with an estimated global prevalence of up to 14%. While lifestyle and genetic risk factors for GDM are well documented, the effect of probiotic supplementation on the management of GDM-specifically through the reduction of insulin resistance as measured by the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) index-has not been systematically evaluated. Objective This meta-analysis aimed to quantitatively evaluate the clinical efficacy of probiotic supplementation in reducing the HOMA-IR index in a population of pregnant women with diagnosed GDM who manage the disease without the use of antidiabetic pharmacotherapy (insulin or oral agents), as well as to address the probiotics as an evidence-based, adjunctive therapeutic strategy for a more effective regulation of the metabolic profile during pregnancy. Methods PubMed, Scopus, and Cochrane databases were searched for original research articles published up to August 10, 2025, which could potentially evaluate the impact of oral probiotic supplementation to the reduction of the HOMA-IR insulin resistance index in pregnant women with GDM without antidiabetic medication during the current pregnancy. A random-effects model was applied to estimate weighted mean differences (MDs) and 95% confidence intervals (CIs). Results Four randomized controlled trials comprising 245 women (128 in the probiotic group and 126 in the placebo group) were included. The meta-analysis demonstrated a statistically significant reduction in the HOMA-IR levels in the intervention group compared to the control group (weighted MD: -0.51, 95% CI: -0.90 to -0.11, p = 0.01). Significant heterogeneity was observed among the studies (I2 = 61.3%). Conclusion The administration of probiotics appears to improve insulin sensitivity in women with GDM and may serve as a useful adjunctive therapy.
SN - 2090-9098
SN - 1110-7782
ER -